Ulland Investment Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-41
Closed -$7K – 248
2023
Q4
$7K Hold
41
– – 0.01% 171
2023
Q3
$7K Hold
41
– – 0.01% 181
2023
Q2
$6K Hold
41
– – 0.01% 182
2023
Q1
$7K Hold
41
– – 0.01% 169
2022
Q4
$7K Hold
41
– – 0.01% 172
2022
Q3
$8K Hold
41
– – 0.01% 175
2022
Q2
$7K Hold
41
– – 0.01% 199
2022
Q1
$8K Hold
41
– – 0.01% 206
2021
Q4
$11K Buy
+41
New +$11K 0.01% 174

Other funds holding RGEN

Ulland Investment Advisors's RGEN Position: Q1 2024 in Review

Ulland Investment Advisors sold out of Repligen (RGEN) in Q1 2024, closing a stake of 41 shares — an estimated $7K sold.

Ulland Investment Advisors first reported a position in RGEN in Q4 2021 and held it in 9 quarters. The position peaked at $11K in Q4 2021. 487 funds tracked by Wall St. Rank hold RGEN as of Q1 2024.

  • Ulland Investment Advisors reported no remaining Repligen position as of Q1 2024 after selling out during the quarter.
  • Ulland Investment Advisors sold 41 Repligen shares in Q1 2024, an estimated $7K.
  • Ulland Investment Advisors first reported a position in Repligen in Q4 2021 and held it in 9 quarters.
  • Ulland Investment Advisors's Repligen position peaked at $11K in Q4 2021.
  • 487 funds tracked by Wall St. Rank held Repligen as of Q1 2024.

Based on Ulland Investment Advisors's 13F filing for Q1 2024, filed 25 Apr 2024.